Chronic Eosinophilic Leukemia (CEL)

Also known as: Chronic eosinophilic leukemia / Chronic eosinophilic leukaemia

DrugDrug NameDrug Description
DB00619ImatinibImatinib is a small molecule kinase inhibitor used to treat certain types of cancer. It is currently marketed by Novartis as Gleevec (USA) or Glivec (Europe/Australia) as its mesylate salt, imatinib mesilate (INN). It is occasionally referred to as CGP57148B or STI571 (especially in older publications). It is used in treating chronic myelogenous leukemia (CML), gastrointestinal stromal tumors (GISTs) and a number of other malignancies. It is the first member of a new class of agents that act by inhibiting particular tyrosine kinase enzymes, instead of non-specifically inhibiting rapidly dividing cells.
DrugDrug NamePhaseStatusCount
DB01413Cefepime1Completed1
DB00987Cytarabine1Completed1
DB00773Etoposide1Completed1
DB00619Imatinib1Completed1
DB01268Sunitinib1Completed1
DB02546Vorinostat1Completed1
DB00394Beclomethasone dipropionate2Completed1
DB01008Busulfan2Recruiting1
DB00531Cyclophosphamide2Recruiting1
DB01609Deferasirox2Terminated1
DB01073Fludarabine2Completed1
DB01073Fludarabine2Recruiting1
DB00619Imatinib2Completed1
DB00563Methotrexate2Completed1
DB00688Mycophenolate mofetil2Recruiting1
DB00904Ondansetron2Completed1
DB00864Tacrolimus2Completed1
DB00864Tacrolimus2Recruiting1
DB11940Triapine2Completed1
DB09312Antilymphocyte immunoglobulin (horse)Not AvailableActive Not Recruiting1
DB00098Antithymocyte immunoglobulin (rabbit)Not AvailableActive Not Recruiting1
DB00091CyclosporineNot AvailableCompleted1
DB01073FludarabineNot AvailableActive Not Recruiting1
DB01073FludarabineNot AvailableCompleted1
DB00529FoscarnetNot AvailableCompleted1
DB01004GanciclovirNot AvailableCompleted1
DB01356LithiumNot AvailableCompleted1
DB01042MelphalanNot AvailableActive Not Recruiting1
DB00688Mycophenolate mofetilNot AvailableCompleted1
DB00039PaliferminNot AvailableCompleted1
DB01610ValganciclovirNot AvailableCompleted1